EnteroMedics files $75M mixed securities shelf
moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
ETRM
ENTEROMEDICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
EnteroMedics’ CEO Discusses Q1 2014 Results – Earnings Call Transcript
[at Seeking Alpha] – Greg Lea Thank you, Mark. For the three months ended March 31, 2014, the Company reported a net loss of 6.7 million, or a $0.10 per share. Research and development expenses were 2.6 million and general … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics […]
7:01 am EnteroMedics announces the FDA has rescheduled the Advisory Committee Meeting date to June 17, 2014 for review of Maestro rechargeable system
moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
Trend Report: 7 Insider And Hedge Fund Stock Picks To Consider
moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
[Marketwired] – EnteroMedics Inc. , the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statement
moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
7:01 am EnteroMedics announces FDA Advisory Committee meeting date for review of the Maestro Rechargeable System for the treatment of obesity; Center for Devices and Radiologic Health Advisory Committee scheduled for May 29, 2014
moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
EnteroMedics Reports Fourth Quarter 2013 Financial Results
[Marketwired] – EnteroMedics Inc. , the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced financial results for the … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
EnteroMedics Announces Food and Drug Administration Advisory Committee Meeting Date for Review of the Maestro(R) Rechargeable System for the Treatment of Obesity
[Marketwired] – EnteroMedics Inc. , the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the U.S. Food and Drug … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
